Checkpoint Therapeutics I... (CKPT)
NASDAQ: CKPT
· Real-Time Price · USD
4.16
0.01 (0.24%)
At close: May 15, 2025, 3:59 PM
4.15
-0.12%
After-hours: May 15, 2025, 04:05 PM EDT
Checkpoint Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2021 |
|---|---|
| PD-L1 GITR Revenue | 21.5M |
| PD-L1 GITR Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 12.02M | 3.36M | 2.23M | 2.45M | 1.88M | 2.24M | 2.28M | 2.29M | 2.48M | 1.85M | 2.13M | 2.24M | 2.13M | 1.92M | 2.11M | 2.37M | 2.12M | 2.43M | 1.69M | 1.68M | 2.15M | 1.62M | 1.76M | 1.7M | 1.5M | 1.54M | 1.35M | 2.19M | 1.35M | 1.34M | 1.32M | 1.4M | 1.09M | 972K | 1.22M | 1.18M | 2.16M | 219K | 31K | 82K |
| Selling, General, and Administrative Revenue Growth | +257.95% | +50.31% | -8.85% | +30.65% | -16.10% | -1.97% | -0.48% | -7.66% | +34.45% | -13.29% | -5.08% | +5.40% | +10.66% | -9.04% | -10.91% | +11.72% | -12.56% | +43.98% | +0.54% | -22.03% | +32.84% | -7.85% | +3.23% | +13.38% | -2.72% | +14.20% | -38.38% | +61.92% | +0.82% | +2.05% | -6.13% | +28.72% | +12.14% | -20.39% | +3.12% | -45.08% | +884.47% | +606.45% | -62.20% | n/a |
| Research and Development Revenue | 16.81M | 6.37M | 4.48M | 8.5M | 8.3M | 5.5M | 13.95M | 15.83M | 14.24M | 8.87M | 12.05M | 14.67M | 27.66M | 9.38M | 7.2M | 4.21M | 8.14M | 2.54M | 3.03M | 2.63M | 6.73M | 3.89M | 4.12M | 4.58M | 13.42M | 7.85M | 5.45M | 6.93M | 4.92M | 4.96M | 5.51M | 3.7M | 7.74M | 4.71M | 5.45M | 2.37M | 5.36M | 3.48M | 444K | 2.04M |
| Research and Development Revenue Growth | +164.04% | +42.10% | -47.28% | +2.39% | +51.00% | -60.59% | -11.89% | +11.17% | +60.57% | -26.44% | -17.84% | -46.96% | +194.74% | +30.37% | +70.85% | -48.28% | +220.29% | -16.04% | +14.95% | -60.85% | +72.83% | -5.49% | -10.06% | -65.87% | +71.01% | +43.92% | -21.34% | +41.01% | -0.79% | -10.01% | +48.65% | -52.16% | +64.29% | -13.46% | +130.27% | -55.87% | +53.77% | +684.91% | -78.18% | n/a |